Ronald Gieschke
Grenzacher Street 124
Basel, BS, Switzerland
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Development of a quantitative semi-mechanistic model of Alzheimer's disease based on the amyloid/tau/neurodegeneration framework (the Q-ATN model).
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: July 29, 2022
In silico exploration of amyloid-related imaging abnormalities in the gantenerumab open-label extension trials using a semi-mechanistic model.
Journal: Alzheimer's & dementia (New York, N. Y.)
Published: February 22, 2022
Disease Modeling and Model-Based Meta-Analyses to Define a New Direction for a Phase III Program of Gantenerumab in Alzheimer's Disease.
Journal: Clinical pharmacology and therapeutics
Published: September 22, 2021
Use of quantitative clinical pharmacology to improve early clinical development success in neurodegenerative diseases.
Journal: Expert review of clinical pharmacology
Published: July 19, 2018
Mathematical Disease Progression Modeling in Type 2/3 Spinal Muscular Atrophy.
Journal: Muscle & nerve
Published: November 10, 2017
Model Description Language (MDL): A Standard for Modeling and Simulation.
Journal: CPT: pharmacometrics & systems pharmacology
Published: January 17, 2017
Erratum for Kamal et al., A Drug-Disease Model Describing the Effect of Oseltamivir Neuraminidase Inhibition on Influenza Virus Progression.
Journal: Antimicrobial agents and chemotherapy
Published: February 28, 2016
A drug-disease model describing the effect of oseltamivir neuraminidase inhibition on influenza virus progression.
Journal: Antimicrobial agents and chemotherapy
Published: January 09, 2015
A semi-mechanistic model of bone mineral density and bone turnover based on a circular model of bone remodeling.
Journal: Journal of pharmacokinetics and pharmacodynamics
Published: June 23, 2014
Modeling Alzheimer's Disease Progression Using Disease Onset Time and Disease Trajectory Concepts Applied to CDR-SOB Scores From ADNI.
Journal: CPT: pharmacometrics & systems pharmacology
Published: June 06, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026